Based on the data, the import of pharmaceutical products to Spain showed a fluctuating trend over the years 2013 to 2023, reaching a value of 16.756 billion USD in 2023. The year-on-year variation in 2023 was 1.76%, suggesting a modest increase from the previous year. The compound annual growth rate (CAGR) over the past five years (2018-2023) was 1.38%, indicating consistent but moderate growth.
From 2024 onward, the import values are forecasted to show a steady increase, with a projected value of 18.202 billion USD by 2028. The forecasted five-year CAGR (2024-2028) stands at 1.18%, reflecting a continued but slightly lower growth rate compared to the previous period.
Future trends to watch for in the Spanish pharmaceutical import market include:
- The impact of regulatory changes and healthcare reforms.
- Advancements in biopharmaceuticals and personalized medicine, which may drive higher imports of specialized drugs.
- Global supply chain disruptions, which could affect the consistency of pharmaceutical imports.
- Changes in demand due to demographic shifts and the aging population in Spain.
- Economic factors such as currency fluctuations and trade policies, influencing the cost and volume of imports.
